PER 0.00% 8.0¢ percheron therapeutics limited

Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-190

  1. 2,977 Posts.
    lightbulb Created with Sketch. 497
    Unfortunately nothing much will change until we get some decent news - one would think that management could provide us with an update on proceedings, to stop the slide... that would be asking too much from this mob!
    Best just not to watch the share price shenanigans goings-on - fundamentals haven't changed... I guess patience is still the key, however painful it is!
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.